News
Can Conference Save Orphan Drug Tax Credit? Orphan drug developers will be watching closely in the next few days as the GOP’s tax reform package…
Read MoreFor the third straight month, the OIS Index outperformed the NASDAQ Biotechnology Index. The OIS Index gained 2.6% in November, nearly matching the performance of…
Read MoreThe forces driving ophthalmic innovation are digitization and demographics, namely in the emergence of millennials, and how the major players in ophthalmology respond to those…
Read MoreHere’s a review of clinical trial results and new technology rolled out at the latest gathering of the American Academy of Ophthalmology in New Orleans.…
Read MoreGAITHERSBURG, MD – Digital Health devices can help detect eye disease in various health-care settings, although ophthalmic practices need to carefully monitor data they generate,…
Read MoreThe OIS Index is a composite of ophthalmic growth stocks that tracks the investment performance of our sector. Our goal is to highlight ophthalmology investment…
Read MoreLet’s just say there’s too much happening at OIS@AAO 2017 next week to capsulize it all in a tidy preview, but with the ninth iteration…
Read MoreWhen Food and Drug Administration Commissioner Scott Gottlieb, MD, announced a new agency-wide initiative last summer called the Digital Health Innovation Plan, the goal was…
Read MoreWith the unanimous endorsement from a Food and Drug Administration advisory committee that Spark Therapeutics’ Luxturna gene therapy for biallelic RPE65 mutation-associated retinal dystrophy should…
Read MoreThe workshop on Ophthalmic Digital Health, a collaboration of the Food and Drug Administration and a host of medical societies that aims to explore safety…
Read MoreWhat’s Happening in the Month Ahead: October 2017 The Food and Drug Administration along with a host of professional societies, including the American Academy of…
Read MoreOne year ago, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.